Results of a prospective randomized trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) alone vs. ABVD plus radiation therapy for early stage non bulky Hodgkin's disease.

被引：0
|
作者：
Straus, DJ [1 ]
Yahalom, J [1 ]
Zelenetz, AD [1 ]
Qin, J [1 ]
Myers, J [1 ]
Moskowitz, CH [1 ]
Noy, A [1 ]
Bertino, JR [1 ]
Portlock, CS [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3201
引用
收藏
页码：769A / 769A
页数：1
相关论文
共 50 条
  • [21] BEACOPP and COPP/ABVD as salvage treatment after primary extended field radiation therapy of early stage Hodgkins disease -: Results of the German Hodgkin Study Group
    Rüffer, JU
    Ballova, V
    Glossmann, J
    Sieber, M
    Franklin, J
    Nogova, L
    Diehl, V
    Josting, A
    LEUKEMIA & LYMPHOMA, 2005, 46 (11) : 1561 - 1567
  • [22] A Randomized Phase III Trial of ABVD Vs. Stanford V +/- Radiation Therapy In Locally Extensive and Advanced Stage Hodgkin's Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperatve Oncology Group (E2496)
    Gordon, Leo I.
    Hong, Fanxing
    Fisher, Richard I.
    Bartlett, Nancy L.
    Connors, Joseph M.
    Gascoyne, Randy D.
    Wagner, Henry
    Stiff, Patrick J.
    Cheson, Bruce D.
    Gospodarowicz, Mary
    Advani, Ranjana
    Kahl, Brad
    Friedberg, Jonathan W.
    Blum, Kristie A.
    Habermann, Thomas M.
    Tuscano, Joseph
    Hoppe, Richard
    Horning, Sandra J.
    BLOOD, 2010, 116 (21) : 185 - 185
  • [23] Prospective clinical trial comparing chemotherapy, radiotherapy and combined therapy in the treatment of early stage Hodgkin's disease with bulky disease
    Aviles, A
    Delgado, S
    CLINICAL AND LABORATORY HAEMATOLOGY, 1998, 20 (02): : 95 - 99
  • [24] ABVD vs. STANFORD V (SV) vs. MOPP-EBV-CAD (MEC) in advanced Hodgkin's lymphoma. Final results of the IIL HD9601 randomized trial.
    Federico, M
    Levis, A
    Luminari, S
    Chisesi, T
    Marcheselli, L
    Goldaniga, M
    Vitolo, U
    Neri, S
    Brugiatelli, M
    Gobbi, PG
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 559S - 559S
  • [25] Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a multicenter phase II study (JCOG 8905)
    Takenaka, T
    Mikuni, C
    Miura, A
    Sasaki, T
    Suzuki, H
    Hotta, T
    Hirano, M
    Fukuhara, S
    Sugiyama, H
    Nasu, K
    Dohi, H
    Kozuru, M
    Tomonaga, M
    Tajima, K
    Niimi, M
    Fukuda, H
    Mukai, K
    Shimoyama, M
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2000, 30 (03) : 146 - 152
  • [26] Four cycles of ABVD followed by involved field irradiation (IF-RT) is the treatment of choice for early-stage Hodgkin's disease (HD): 5-year results of a randomized trial
    Santoro, A
    Bonfante, V
    Viviani, S
    Zanini, M
    Devizzi, L
    Parra, HS
    DiRusso, A
    Soncini, F
    Villani, F
    Valagussa, P
    Bonadonna, G
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1185 - 1185
  • [27] Long-term results of a prospective trial of mantle irradiation alone for early-stage Hodgkin's disease
    Ng, A. K.
    Li, S.
    Neuberg, D.
    Fisher, D. C.
    McMillan, C.
    Silver, B.
    Marcus, K. C.
    Stevenson, M. A.
    Mauch, P. M.
    ANNALS OF ONCOLOGY, 2006, 17 (11) : 1693 - 1697
  • [28] Brentuximab Vedotin Plus Doxorubicin, Vinblastine, and Dacarbazine as Frontline Therapy Demonstrates Superior Modified Progression-Free Survival Versus ABVD in Patients With Previously Untreated Stage III or IV Hodgkin Lymphoma: The Phase 3 ECHELON-1 Study
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (02) : 7 - 8
  • [29] Brentuximab Vedotin Plus Doxorubicin, Vinblastine, Dacarbazine (A plus AVD) As Frontline Therapy Demonstrates Superior Modified Progression-Free Survival Versus ABVD in Patients with Previously Untreated Stage III or IV Hodgkin Lymphoma (HL): The Phase 3 Echelon-1 Study
    Connors, Joseph M.
    Jurczak, Wojciech
    Straus, David J.
    Ansell, Stephen M.
    Kim, Won Seog
    Gallamini, Andrea
    Younes, Anas
    Alekseev, Sergei
    Illes, Arpad
    Picardi, Marco
    Lech-Maranda, Ewa
    Oki, Yasuhiro
    Feldman, Tatyana A.
    Smolewski, Piotr
    Savage, Kerry J.
    Bartlett, Nancy L.
    Walewski, Jan
    Chen, Robert W.
    Ramchandren, Rod
    Zinzani, Pier Luigi
    Cunningham, David
    Heo, Dae Seog
    Rosta, Andras
    Josephson, Neil
    Ruffner, Katherine L.
    Sachs, Jessica
    Liu, Rachael
    Jolin, Hina
    Huebner, Dirk
    Radford, John A.
    BLOOD, 2017, 130
  • [30] Long-term results of a prospective trial of mantle irradiation (RT) alone for early-stage Hodgkin's disease
    Ng, A
    Li, S
    Neuberg, D
    Silver, B
    Stevenson, MA
    Mauch, PM
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S45 - S46
12345